Cheng Sohanya Roshan bought KPTI
May 13, 2026 · Form 4 insider transaction
Cheng Sohanya Roshan bought 947 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
947
Price
$0.00
Total value
N/A
InsiderCheng Sohanya Roshan
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 13, 2026
Filing dateMay 15, 2026
Shares owned after108,264
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026.